Daryl Lau

Beth Israel Deaconess Medical Center

Papers

1

Total Citations

8

H-Index

1

About

Daryl Lau is a leading hepatologist whose research focuses on the genetic and molecular underpinnings of severe liver diseases, particularly hepatitis B virus (HBV) infection and acute liver failure. Her major contributions include identifying host genetic variants that influence disease susceptibility and progression, with her most-cited work, "Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus–Related Acute Liver Failure" (2018, 8 citations), highlighting how a specific polymorphism in the CXCL16 gene could predispose individuals to this life-threatening condition. This finding offers critical insights into the interplay between viral pathogenesis and host genetics, potentially guiding risk stratification and personalized therapies. Beyond this, Lau’s research addresses the global burden of HBV, which affects 1.25 million people in the U.S. and 250 million worldwide, emphasizing the need for targeted interventions. Her work has been recognized for its translational impact, bridging basic genetic discoveries with clinical applications in hepatology. For students and researchers, Lau exemplifies how integrating genomics and virology can unravel complex disease mechanisms, paving the way for improved diagnostics and treatments in liver health.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus–Related Acute Liver Failure
8 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Beth Israel Deaconess Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago